MODD logo

MODULAR MEDICAL INC

MODDNASDAQ
πŸ† #4836 by market capUS Equity
$218.00β–Ό $12.86 (βˆ’5.90%)
Simulated price
πŸ””
Track MODD
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 5.9%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$16M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
28
Weak
No chart data available for MODD.

Trading Snapshot

Day Range
$215.09 – $222.10
52-Week Range
$1.72 – $21.87
Volume
$3.27B
Avg Volume
$3.30B
Shares Outstanding
5.4M
Next Earnings
Dec 12, 2026

Fundamentals Snapshot

Annual Revenue
$2M
Last Q Revenue
$413,206
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
$-10.69
Dividend Yield
β€”
Dilution (1yr)
+148.1%

Why Investors Own MODD

  • βœ“High-growth profile β€” revenue up -7.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 26% gross margin and 14% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

MODD logo

MODULAR MEDICAL INC

MODD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$28Mβ–² +44.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$28Mβ–² +52.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.5Mβ–² +148.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$4Mβ–² +$1M YoY
StockOtter Β· stockotter.space

About MODULAR MEDICAL INC

Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
28/100

Analyst Price Target

β“˜
Average Target
$234.47
β–² +7.6% Upside
High Target$258.25
Low Target$188.53
Based on 13 analysts

Latest News & Updates